Dissecting the pathways that destabilize mutant p53: The proteasome or autophagy?

作者: Sujata Choundhury , Vamsi Kolukula , Anju Preet , Chris Albanese , maria avantaggiati

DOI: 10.4161/CC.24128

关键词:

摘要: One fundamental feature of mutant forms p53 consists in their accumulation at high levels tumors. At least the case neomorphic mutations, which acquire oncogenic activity, stabilization is a driving force for tumor progression. It well documented that mutants are resistant to proteasome-dependent degradation compared with wild-type p53, but exact identity pathways affect stability still debated. We have recently shown macroautophagy (autophagy) provides route during restriction glucose. Here we further show basal conditions growth, inhibition autophagy chemical inhibitors or by downregulation essential autophagic genes ATG1/Ulk1, Beclin-1 ATG5, results stabilization. Conversely, overexpression ATG1/Ulk1 leads depletion. Furthermore, found many cell lines, prolonged proteasome does not stabilize its autophagic-mediated degradation. Therefore, conclude key mechanism regulating several mutants. discuss plausible mechanisms involved this newly identified pathway as possible role played evolution driven p53.

参考文章(50)
Steinberg Sm, Mulshine Jl, Linnoila Ri, Ebina M, Relationship of p53 Overexpression and Up-Regulation of Proliferating Cell Nuclear Antigen with the Clinical Course of Non-Small Cell Lung Cancer Cancer Research. ,vol. 54, pp. 2496- 2503 ,(1994)
Marco Napoli, Javier E. Girardini, Silvano Piazza, Giannino Del Sal, Wiring the oncogenic circuitry: Pin1 unleashes mutant p53. Oncotarget. ,vol. 2, pp. 654- 656 ,(2011) , 10.18632/ONCOTARGET.329
Ilker Kudret Sariyer, Nana Merabova, Prem Kumer Patel, Tijana Knezevic, Alessandra Rosati, Maria C. Turco, Kamel Khalili, Bag3-induced autophagy is associated with degradation of JCV oncoprotein, T-Ag. PLOS ONE. ,vol. 7, ,(2012) , 10.1371/JOURNAL.PONE.0045000
Jie Xu, Joke Reumers, José R Couceiro, Frederik De Smet, Rodrigo Gallardo, Stanislav Rudyak, Ann Cornelis, Jef Rozenski, Aleksandra Zwolinska, Jean-Christophe Marine, Diether Lambrechts, Young-Ah Suh, Frederic Rousseau, Joost Schymkowitz, Gain of function of mutant p53 by coaggregation with multiple tumor suppressors Nature Chemical Biology. ,vol. 7, pp. 285- 295 ,(2011) , 10.1038/NCHEMBIO.546
Esther Wong, Eloy Bejarano, Moumita Rakshit, Karen Lee, Hugo H. Hanson, Nava Zaarur, Greg R. Phillips, Michael Y. Sherman, Ana Maria Cuervo, Molecular determinants of selective clearance of protein inclusions by autophagy Nature Communications. ,vol. 3, pp. 1240- 1240 ,(2012) , 10.1038/NCOMMS2244
Ran Brosh, Varda Rotter, When mutants gain new powers: news from the mutant p53 field Nature Reviews Cancer. ,vol. 9, pp. 701- 713 ,(2009) , 10.1038/NRC2693
Udai Bhan Pandey, Zhiping Nie, Yakup Batlevi, Brett A. McCray, Gillian P. Ritson, Natalia B. Nedelsky, Stephanie L. Schwartz, Nicholas A. DiProspero, Melanie A. Knight, Oren Schuldiner, Ranjani Padmanabhan, Marc Hild, Deborah L. Berry, Dan Garza, Charlotte C. Hubbert, Tso-Pang Yao, Eric H. Baehrecke, J. Paul Taylor, HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS Nature. ,vol. 447, pp. 859- 863 ,(2007) , 10.1038/NATURE05853
Pengrong Yan, Guoliang Qing, Zhaoxia Qu, Chang-Chih Wu, Arnold Rabson, Gutian Xiao, Targeting Autophagic Regulation of NF-kappaB in HTLV-I Transformed Cells by Geldanamycin: Implications for Therapeutic Interventions Autophagy. ,vol. 3, pp. 600- 603 ,(2007) , 10.4161/AUTO.4761
Olga Catalina Rodriguez, Sujatra Choudhury, Vamsi Kolukula, Eveline E. Vietsch, Jason Catania, Anju Preet, Katherine Reynoso, Jill Bargonetti, Anton Wellstein, Chris Albanese, Maria Laura Avantaggiati, Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle. ,vol. 11, pp. 4436- 4446 ,(2012) , 10.4161/CC.22778